ReviewPharmacy (Basel, Switzerland)2026
A Systematic Review of Pharmacists Using Motivational Interviewing and Patient Outcomes.
Review in Pharmacy (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients often must change their behaviors to prevent and mitigate the impact of chronic disease, yet deciding to begin and adhere to these changes can be challenging. Motivational interviewing (MI), a patient-centered communication approach, has been utilized by pharmacists to support patients in making these changes. Thus, this systematic review aimed to describe the outcomes of MI interventions by pharmacists and student pharmacists.
methodsUsing PRISMA methodology and registered in PROSPERO (CRD42024546509), PubMed, CINAHL, and Web of Science were searched for articles matching the study objective (pharmacists, motivational interviewing, and patient outcomes) from January 2014 to April 2024. Two reviewers independently screened titles, abstracts, and full texts. Data from included articles were extracted, synthesized categorically, and underwent quality assessment using the Mixed Methods Assessment Test.
resultsOut of 356 identified articles, 45 were included. Randomized controlled trial designs implemented in ambulatory care or community pharmacies in the Global North were most common. Studies most frequently addressed diabetes, hypertension, and smoking cessation. Overall, MI interventions were associated with positive or neutral outcomes, with no studies reporting worsened results. Conditions such as hypertension and lipidemia and the need for nicotine cessation had positive outcomes, while diabetes and cardiovascular conditions contained both positive and neutral outcomes.
conclusionsGiven its low implementation burden, MI represents a potential strategy for pharmacists and student pharmacists to improve patient outcomes, though future research should evaluate intervention fidelity and expand settings studied.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.